Expertise in
36
conditions

Dr. Amy Sanford

Hematology
Sanford Clinic
1309 W 17th St Ste 101, 
Sioux Falls, SD 
Offers Telehealth
17 Years of Experience
Expertise in
36
conditions
Sanford Clinic
1309 W 17th St Ste 101, 
Sioux Falls, SD 

Overview

Amy Sanford is a Hematologist in Sioux Falls, South Dakota. Dr. Sanford has been practicing medicine for over 17 years is highly rated in 36 conditions, according to our data. Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 4 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year

2009

Specialties

Hematology

Licenses

Internal Medicine in IA

Hospital Affiliations

Avera Merrill Pioneer Hospital
Sioux Center Health
Avera Queen Of Peace
Avera Mckennan Hospital & University Health Center
Spencer Municipal Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avera Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 9 Less Insurance Carriers -

Locations

Sanford Clinic
1309 W 17th St Ste 101, Sioux Falls, SD 57104
Other Locations
Office
1000 E 23rd St Ste 230, Sioux Falls, SD 57105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Active_not_recruiting
Publish Date: December 30, 2025
Intervention Type: Drug, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Carboplatin, Cetuximab
Study Phase: Phase 2
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Phase I Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Low-Expressing (IHC 1+/2+) Breast Cancer
Phase I Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Low-Expressing (IHC 1+/2+) Breast Cancer
Enrollment Status: Terminated
Publish Date: January 13, 2025
Intervention Type: Biological
Study Drug: ETBX-021
Study Phase: Phase 1
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug, Radiation, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Cetuximab
Study Phase: Phase 2
ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial
ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial
Enrollment Status: Withdrawn
Publish Date: November 18, 2023
Intervention Type: Drug
Study Phase: Phase 1
View 4 Less Clinical Trials

4 Total Publications

Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Journal: Nature medicine
Published: August 07, 2024
Similar Doctors
Expertise in
70
conditions
Dr. Jonathan Bleeker
Hematology
Expertise in
70
conditions
Dr. Jonathan Bleeker
Hematology

Sanford Clinic

1309 W 17th St Ste 101, 
Sioux Falls, SD 
 (4.9 miles away)
605-328-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonathan Bleeker is a Hematologist in Sioux Falls, South Dakota. Dr. Bleeker is highly rated in 70 conditions, according to our data. His top areas of expertise are Ataxia-Pancytopenia Syndrome, Fanconi Anemia, Shwachman-Diamond Syndrome, Pancreatic Cancer, and Bone Marrow Aspiration.

Expertise in
53
conditions
Dr. Vinod Parameswaran
Hematology | Oncology
Expertise in
53
conditions
Dr. Vinod Parameswaran
Hematology | Oncology

Avera Medical Group Hematology

1000 E 23rd St Ste 200, 
Sioux Falls, SD 
 (1.5 miles away)
605-322-3035
Languages Spoken:
English
See accepted insurances

Vinod Parameswaran is a Hematologist and an Oncologist in Sioux Falls, South Dakota. Dr. Parameswaran is highly rated in 53 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Multiple Myeloma, Diencephalic Syndrome, Bone Marrow Aspiration, and Bone Marrow Transplant.

Expertise in
53
conditions
Dr. Christopher Sumey
Hematology
Expertise in
53
conditions
Dr. Christopher Sumey
Hematology

Sanford Clinic

1309 W 17th St Ste 101, 
Sioux Falls, SD 
 (4.9 miles away)
605-328-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Christopher Sumey is a Hematologist in Sioux Falls, South Dakota. Dr. Sumey is highly rated in 53 conditions, according to our data. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Amy Sanford

How do I make an appointment with Dr. Amy Sanford?

You can book an appointment with Dr. Amy Sanford by calling their office at 605-328-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Amy Sanford a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amy Sanford is classified as an Distinguished expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Amy Sanford specialize in?

While Dr. Amy Sanford is a Hematology, they have specific expertise in Chronic Lymphocytic Leukemia (CLL), Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Amy Sanford participate in research or clinical trials?

Yes. Dr. Amy Sanford has published 4 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Dr. Amy Sanford's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Amy Sanford accept my insurance?

Dr. Amy Sanford accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 605-328-8000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sanford's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 27 Advanced Conditions
    View All 128 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile